1.Goodenberger MKL, Jenkins RB, Genetics of adult glioma. Cancer Genetics. 2012;205:613–21.
2.Desouza RM, Shaweis H, Han C, Sivasubramiam V, Brazil L, Beaney R, et al, Has the survival of patients with glioblastoma changed over the years? British journal of cancer. 2016;114:146–50.
3.Qi L, Ding L, Wang S, Zhong Y, Zhao D, Gao L, et al, A network meta-analysis: the overall and progression-free survival of glioma patients treated by different chemotherapeutic interventions combined with radiation therapy (RT). Oncotarget. 2016;7:69002–13.
4.Y L, X H, W L, C L, J G, Z M, Y T, Analysis of Survival Prognosis for Children with Symptomatic Optic Pathway Gliomas Who Received Surgery. World neurosurgery. 2018;109:e1-e15.
5.Golson ML, Kaestner KH, Fox transcription factors: from development to disease. Development. 2016;143:4558–70.
6.Schafer S, Behling F, Skardelly M, Koch M, Ott I, Paulsen F, Tabatabai G, Schittenhelm J, Low FoxG1 and high Olig–2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas. Neuropathol Appl Neurobiol. 2018;44:207–23.
7.Wu H, Qian C, Liu C, Xiang J, Ye D, Zhang Z, Zhang X, Role and mechanism of FOXG1 in invasion and metastasis of colorectal cancer. Sheng wu gong cheng xue bao Chinese journal of biotechnology. 2018;34:752.
8.T K, C H, Evolutionary conservation and conversion of Foxg1 function in brain development. Development, growth & differentiation. 2017;59:258–69.
9.Cui J, Gong Z, Shen HM, The role of autophagy in liver cancer: molecular mechanisms and potential therapeutic targets. Biochimica et biophysica acta. 2013;1836:15–26.
10.Xue Z, Guo Y, Fang Y, Moderate activation of autophagy regulates the intracellular calcium ion concentration and mitochondrial membrane potential in beta-amyloid-treated PC12 cells. Neurosci Lett. 2016;618:50–7.
11.KX J, F C, D Q, RY S, P S, FY C, SL W, HS S, MiR–378 promotes the cell proliferation of non-small cell lung cancer by inhibiting FOXG1. European review for medical and pharmacological sciences. 2018;22:1011–9.
12.N B-P, AR P, R C, E DM, MC B, R B, et al, Duplications of FOXG1 in 14q12 are associated with developmental epilepsy, mental retardation, and severe speech impairment. European journal of human genetics: EJHG. 2011;19:102–7.
13.MN M, B M, MD M, JC Q, C K, JO M, DJ P, The transcription factor Foxg1 regulates telencephalic progenitor proliferation cell autonomously, in part by controlling Pax6 expression levels. Neural development. 2011;6:9.
14.M B, C P, M G, C F, A M, Emx2 and Foxg1 inhibit gliogenesis and promote neuronogenesis. Stem cells (Dayton, Ohio). 2010;28:1206–18.
15.AM A, Y N, V M, H T, P S, S C, M C, MK G, FOXG1 dysregulation is a frequent event in medulloblastoma. Journal of neuro-oncology. 2007;85:111–22.
16.Adesina AM, Veo BL, Courteau G, Mehta V, Wu X, Pang K, Liu Z, Li XN, Peters L, FOXG1 expression shows correlation with neuronal differentiation in cerebellar development, aggressive phenotype in medulloblastomas, and survival in a xenograft model of medulloblastoma. Human Pathology. 2015;46:1859–71.
17.Chan DW, Liu VWS, To RMY, Chiu PM, Lee WYW, Yao KM, Cheung ANY, Ngan HYS, Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer. British journal of cancer. 2009;101:1433–43.
18.Chen J, Wu X, Xing Z, Ma C, Xiong W, Zhu X, He X, FOXG1 Expression Is Elevated in Glioma and Inhibits Glioma Cell Apoptosis. J Cancer. 2018;9:778–83.
19.Chi KN, Hotte SJ, Yu EY, Dongsheng T, Eigl BJ, Ian T, et al, Randomized phase II study of docetaxel and prednisone with or without OGX–011 in patients with metastatic castration-resistant prostate cancer. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology. 2010;28:4247.
20.Zhou H, Mu X, Chen J, Liu H, Shi W, Xing E, Yang K, Wu G, RNAi silencing targeting RNF8 enhances radiosensitivity of a non-small cell lung cancer cell line A549. International Journal of Radiation Biology. 2013;89:708–15.
21.Schäfer S, Behling F, Skardelly M, Koch M, Ott I, Paulsen F, Tabatabai G, Schittenhelm J, Low FoxG1 and high Olig‐2 labelling indices define a prognostically favorable subset in IDH‐mutant gliomas. Neuropathology & Applied Neurobiology. 2017;44.
22.Wang L, Wang J, Jin T, Zhou Y, Chen Q, FoxG1 facilitates proliferation and inhibits differentiation by downregulating FoxO/Smad signaling in glioblastoma. Biochemical and biophysical research communications. 2018;504:46–53.
23.Zhou QM, Chen QL, Du J, Wang XF, Lu YY, Zhang H, Su SB, Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: a cDNA microarray analysis. Int J Mol Sci. 2014;15:16284–301.
24.S S, F B, M S, M K, I O, F P, G T, J S, Low FoxG1 and high Olig–2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas. Neuropathology and applied neurobiology. 2018;44:207–23.
25.Qian X, Li X, Cai Q, Zhang C, Yu Q, Jiang Y, et al, Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy. Molecular cell. 2017;65:917–31 e6.